Ewa Wybieralska
Ewa Wybieralska
Brigham and Women's Hospital, Harvard Medical School
Verified email at partners.org
Cited by
Cited by
c-Kit–positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy
F Sanada, J Kim, A Czarna, NYK Chan, S Signore, B Ogórek, K Isobe, ...
Circulation research 114 (1), 41-55, 2014
ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARα-mediated inhibition of glioma cell motility in vitro
J Drukala, K Urbanska, A Wilk, M Grabacka, E Wybieralska, L Del Valle, ...
Molecular cancer 9 (1), 159, 2010
Genetically modified adipose tissue− derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice
S Bobis-Wozowicz, K Miekus, E Wybieralska, D Jarocha, A Zawisz, ...
Experimental hematology 39 (6), 686-696. e4, 2011
Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes
S Signore, A Sorrentino, J Ferreira-Martins, R Kannappan, M Shafaie, ...
Circulation 128 (12), 1286-1297, 2013
Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells
K Piwowarczyk, E Wybieralska, J Baran, J Borowczyk, P Rybak, ...
Expert opinion on therapeutic targets 19 (2), 163-176, 2015
Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations
E Wybieralska, K Szpak, A Górecki, P Bonarek, K Miękus, J Drukała, ...
Oncology reports 26 (2), 447-453, 2011
Ascorbic acid inhibits the migration of Walker 256 carcinosarcoma cells
E Wybieralska, M Koza, J Sroka, J Czyż, Z Madeja
Cellular and Molecular Biology Letters 13 (1), 103-111, 2008
DU-145 prostate carcinoma cells that selectively transmigrate narrow obstacles express elevated levels of CX43
K Szpak, E Wybieralska, E Niedziałkowska, M Rak, I Bechyne, M Michalik, ...
Cellular and Molecular Biology Letters 16 (4), 625-637, 2011
New cationic polyprenyl derivative proposed as a lipofecting agent
Z Madeja, M Rak, E Wybieralska, I Różański, M Masnyk, M Chmielewski, ...
Acta Biochimica Polonica 54 (4), 2007
Topographical control of prostate cancer cell migration
M Sarna, E Wybieralska, K Miekus, J Drukala, Z Madeja
Molecular medicine reports 2 (5), 865-871, 2009
Solute-dependent activation of cell motility in strongly hypertonic solutions in Dictyostelium discoideum, human melanoma HTB-140 cells and walker 256 carcinosarcoma cells
W Korohoda, M Kucia, E Wybieralska, M Wianecka-Skoczeń, ...
Cellular & Molecular Biology Letters 16 (3), 412-430, 2011
Role of ephrins in regulation of tumour cell migration
E Wybieralska, E Łaczna, Z Madeja
Postepy biochemii 55 (2), 153, 2009
Response to Letter Regarding Article “Inositol 1, 4, 5-Trisphosphate Receptors and Human Left Ventricular Myocytes”
S Signore, A Sorrentino, J Ferreira-Martins, R Kannappan, M Shafaie, ...
Circulation 129 (21), e510-e511, 2014
Fenofibrate enhances the barrier function of endothelial continuum within the metastatic niche of prostate cancer cells: P06-50
K Szpak, E Wybieralska, J Borowczyk, A Wlodarczyk, M Michalik, K Reiss, ...
The Febs Journal 279, 2012
MET receptor as a key player responsible for malignant properties and intracellular trafficking and fate of CXCR4 in cervical carcinoma cells
K Miekus, M Pawlowska, M Sekula, E Navarro, E Wybieralska, Z Madeja, ...
Cancer Research 72 (8 Supplement), 1204-1204, 2012
The system can't perform the operation now. Try again later.
Articles 1–15